Physician

Salem T. Gaballa, MBBCH

According to 2025 Medicare claims, Salem Gaballa, MBBCH (NPI: 1619471810) practices internal medicine in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Scott, IA. This provider's primary affiliated billing organization is GENESIS HEALTH SYSTEM (NPI: 1528616901; TIN: 363616314) and primary practice location at 52722-7705. Gaballa is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Gaballa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 171 traditional Medicare patients, billed 3,844 HCPCS/CPT codes, and received $69,792 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,712 prescription claims across 238 beneficiaries totaling $894,486 in drug costs, led by Ozempic (Semaglutide). DME data shows 100 claims. Open Payments data shows 6 records totaling $268. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,507 to $894,486. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	87	232	$15,242
2024	171	3,844	$69,792

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	35	85	$4,507
2019	69	176	$16,999
2020	38	191	$37,197
2021	24	129	$24,087
2022	17	87	$56,327
2023	80	314	$190,901
2024	238	1,712	$894,486

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	30	$5,998
2024	48	100	$46,553

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	44	44	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	136	237	$88
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	70	208	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	86	115	$12
83036	Hemoglobin a1c level	45	63	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	253	8,342	$272,263
Mounjaro	Tirzepatide	156	4,874	$178,736
Jardiance	Empagliflozin	123	5,939	$118,700
Farxiga	Dapagliflozin Propanediol	50	2,490	$45,766
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	48	1,680	$39,151

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	33	85	$43,190
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	15	15	$3,363

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$268	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Salem T. Gaballa, MBBCH?

Tedicare shows public-source Medicare data for Salem T. Gaballa, MBBCH (NPI 1619471810), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Salem T. Gaballa, MBBCH have ACO affiliation data?

Salem T. Gaballa, MBBCH is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Salem T. Gaballa, MBBCH?

Salem T. Gaballa, MBBCH is linked to GENESIS HEALTH SYSTEM (billing NPI 1528616901) in the available physician profile data.

Does Salem T. Gaballa, MBBCH have Open Payments data?

Salem T. Gaballa, MBBCH has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.